Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?

Clinical Endocrinology

Volumn 73, Issue 2, 2010, Pages 137-146

  Mooij, Christiaan F ^a   Kroese, Jeanne Margot ^a   Claahsen Van Der Grinten, Hedi L ^a   Tack, Cees J ^a   Hermus, Ad R M M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; GONADORELIN AGONIST; HYDROCORTISONE; MINERALOCORTICOID; PREDNISOLONE; PREDNISONE;

ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BODY MASS; CARDIOVASCULAR RISK; CONGENITAL ADRENAL HYPERPLASIA; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TREND STUDY; TUNICA MEDIA;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; CARDIOVASCULAR DISEASES; CHILD; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; LONG-TERM CARE; METABOLIC DISEASES; RISK FACTORS; TIME FACTORS;

EID: 77954867318     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03690.x     Document Type: Article

References (60)

1. Merke, D.P., Bornstein, S.R., Avila, N.A. et al. (2002) NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Annals of Internal Medicine, 136, 320 334.
2. White, P.C. Speiser, P.W. (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews, 21, 245 291.
3. Etxabe, J. Vazquez, J.A. (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology, 40, 479 484.
4. Charmandari, E. Chrousos, G.P. (2006) Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Annals of the New York Academy of Sciences, 1083, 37 53.
5. New, M.I. (2004) An update of congenital adrenal hyperplasia. Annals of the New York Academy of Sciences, 1038, 14 43.
6. Speiser, P.W., Dupont, B., Rubinstein, P. et al. (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. American Journal of Human Genetics, 37, 650 667.
7. Speiser, P.W. White, P.C. (2003) Congenital adrenal hyperplasia. New England Journal of Medicine, 349, 776 788.
8. Hackam, D.G. Anand, S.S. (2003) Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA, 290, 932 940.
9. Stikkelbroeck, N.M., Oyen, W.J., van der Wilt, G.J. et al. (2003) Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 88, 1036 1042.
10. Falhammar, H., Filipsson, H., Holmdahl, G. et al. (2007) Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 92, 110 116.
11. Bachelot, A., Plu-Bureau, G., Thibaud, E. et al. (2007) Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormone Research, 67, 268 276.
12. Hagenfeldt, K., Martin, R.E., Ringertz, H. et al. (2000) Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. European Journal of Endocrinology, 143, 667 671.
13. Cornean, R.E., Hindmarsh, P.C. Brook, C.G. (1998) Obesity in 21-hydroxylase deficient patients. Archives of Disease in Childhood, 78, 261 263.
14. Völkl, T.M., Simm, D., Beier, C. et al. (2006) Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics, 117, e98 e105.
15. Helleday, J., Siwers, B., Ritzen, E.M. et al. (1993) Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 76, 933 936.
16. Paganini, C., Radetti, G., Livieri, C. et al. (2000) Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Hormone Research, 54, 164 168.
17. Völkl, T.M.K., Simm, D., Körner, A. et al. (2009) Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency? European Journal of Endocrinology, 160, 239 247.
18. King, J.A., Wisniewski, A.B., Bankowski, B.J. et al. (2006) Long-term treatment corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 91, 865 869.
19. Cameron, F.J., Kaymakci, B., Byrt, E.A. et al. (1995) Bone mineral density and body composition in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 80, 2238 2243.
20. Gussinye, M., Carrascosa, A., Potau, N. et al. (1997) Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia. Pediatrics, 100, 671 674. (Pubitemid 27425992)
21. Christiansen, P., Molgaard, C. Muller, J. (2004) Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormone Research, 61, 133 136.
22. Rolland-Cachera, M.F., Deheeger, M., Bellisle, F. et al. (1984) Adiposity rebound in children: a simple indicator for predicting obesity. The American Journal of Clinical Nutrition, 39, 129 135.
23. Merke, D.P., Chrousos, G.P., Eisenhofer, G. et al. (2000) Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. New England Journal of Medicine, 343, 1362 1368.
24. Nonogaki, K. (2000) New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia, 43, 533 549.
25. Ehrhart-Bornstein, M., Breidert, M., Guadanucci, P. et al. (1997) 17 alpha-Hydroxylase and chromogranin A in 6th week human fetal adrenals. Hormone and Metabolic Research, 29, 30 32.
26. Wajchenberg, B.L. (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews, 21, 697 738.
27. Considine, R.V., Sinha, M.K., Heiman, M.L. et al. (1996) Serum immunoreactive-leptin-concentrations in normal-weight and obese humans. New England Journal of Medicine, 334, 292 295.
28. Auwerx, J. Staels, B. (1998) Leptin. The Lancet, 351, 737 742.
29. Mantzoros, C.S. (1999) The role of leptin in human obesity and disease: a review of current evidence. Annals of Internal Medicine, 130, 671 680.
30. Weinsier, R.L., Hunter, G.R., Heini, A.F. et al. (1998) The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity. The American Journal of Medicine, 105, 145 150.
31. Rosenbaum, M. Leibel, R.L. (1998) The physiology of body weight regulation: relevance to the etiology of obesity in children. Pediatrics, 101, 525 539.
32. Wabitsch, M., Jensen, P.B., Blum, W.F. et al. (1996) Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes, 45, 1435 1438.
33. Malmström, R., Taskinen, M.R., Karonen, S.L. et al. (1996) Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia, 39, 993 996. (Pubitemid 26249121)
34. Luukkaa, V., Pesonen, U., Huhtaniemi, I. et al. (1998) Inverse correlation between serum testosterone and leptin in men. Journal of Clinical Endocrinology and Metabolism, 83, 3243 3246.
35. Watanobe, H. Suda, T. (1999) A detailed study of the role of sex steroid milieu in determining plasma leptin concentrations in adult male and female rats. Biochemical and Biophysical Research Communications, 259, 56 59.
36. Charmandari, E., Weise, M., Bornstein, S.R. et al. (2002) Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. Journal of Clinical Endocrinology and Metabolism, 87, 2114 2120.
37. Saygili, F., Oge, A. Yilmaz, C. (2005) Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Hormone Research, 63, 270 274.
38. Bayraktar, F., Dereli, D., Ozgen, A.G. et al. (2004) Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia. Endocrine Journal, 51, 601 608.
39. Sartorato, P., Zulian, E., Benedini, S. et al. (2007) Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 92, 1015 1018.
40. Botero, D., Arango, A., Danon, M. et al. (2000) Lipid profile in congenital adrenal hyperplasia. Metabolism, 49, 790 793.
41. Miranda, P.J., DeFronzo, R.A., Califf, R.M. et al. (2005) Metabolic syndrome: definition, pathophysiology and mechanisms. American Heart Journal, 149, 33 45.
42. de Silva, K.S., Kanumakala, S., Brown, J.J. et al. (2004) 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia - a preliminary report. Journal of Pediatric Endocrinology & Metabolism, 17, 1089 1095.
43. Roche, E.F., Charmandari, E., Dattani, M.T. et al. (2003) Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clinical Endocrinology, 58, 589 596.
44. Völkl, T.M.K., Simm, D., Dötsch, J. et al. (2006) Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 91, 4888 4895.
45. Hoepffner, W., Herman, A., Willgerodt, H. et al. (2006) Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Pediatric Endocrinology & Metabolism, 19, 705 711.
46. Nebesio, T.D. Eugster, E.A. (2006) Observation of hypertension in children with 21-hydroxylase deficiency. A preliminary report. Endocrine, 30, 279 282.
47. National Heart, Lung, and Blood Institute, Bethesda, Maryland 1987) Report of the second task force on blood pressure control in children. Pediatrics, 79, 1 25.
48. Fuller, P.J. Young, M.J. (2005) Mechanisms of mineralocorticoid action. Hypertension, 46, 1227 1235.
49. Hammer, F. Stewart, P.M. (2006) Cortisol metabolism in hypertension. Best practice & research. Clinical Endocrinology & Metabolism, 20, 337 353.
50. Frey, F.J., Odermatt, A. Frey, B.M. (2004) Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Current Opinion in Nephrology and Hypertension, 13, 451 458.
51. Paula, F.J., Gouveia, L.M., Paccola, G.M. et al. (1994) Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia. Hormone and Metabolic Research, 26, 552 556.
52. Speiser, P.W., Serrat, J., New, M.I. et al. (1992) Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 75, 1421 1424.
53. Buffington, C.K., Givens, J.R. Kitabchi, A.E. (1991) Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females. Diabetes, 40, 693 700.
54. Eyzaguirre, F. Mericq, V. (2009) Insulin resistance markers in children. Hormone Research, 71, 65 74.
55. O'Leary, D.H., Polak, J.F., Kronmal, R.A. et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. New England Journal of Medicine, 340, 14 22.
56. Cheng, K.S., Mikhaulidis, D.P., Hamilton, G. et al. (2002) A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovascular Research, 54, 528 538. (Pubitemid 34595411)
57. Hearing, S.D., Norman, M., Smyth, C. et al. (1999) Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. Journal of Clinical Endocrinology and Metabolism, 84, 4149 4154.
58. Rohleder, N., Wolf, J.M. Kirschbaum, C. (2003) Glucocorticoid sensitivity in humans - interindividual differences and acute stress effects. Stress, 6, 207 222.
59. Gross, K.L., Lu, N.Z. Cidlowski, J.A. (2009) Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Molecular and Cellular Endocrinology, 300, 7 16.
60. Kemink, S.A., Frijns, J.T., Hermus, A.R. et al. (1999) Body composition determined by six different methods in women bilaterally adrenalectomized for treatment of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 84, 3991 3999.